Investments, Funding & Disinvestment

The Slovenská Ľupča site will support Evonik’s contract development and manufacturing organization (CDMO) services within its drug substance business.

Spread across approximately 20,000 square metres, the plant is equipped with automated production lines and advanced quality control laboratories built to international pharmaceutical standards.

The Illinois-based drugmaker said the new campus will span 185 acres near Research Triangle Park, one of the country’s leading life sciences clusters.

The new Computational Innovation site will focus on using advanced data science to better understand disease biology and identify biological mechanisms with a higher likelihood of success in drug development.

The partnership aligns with Africa CDC’s Health Security and Sovereignty Agenda, which seeks to help African countries build stronger systems that can prevent, detect, and respond to disease threats while reducing reliance on external support.

The collaboration will enhance the company’s ability to analyze complex datasets, identify promising drug candidates, and significantly reduce the time required to bring medications to patients.

Peak XV Partners leads investment round, with participation from Define Ventures and previous backers.

Biovac will construct the new facility at its Cape Town manufacturing site, with completion expected by 2028.

The acquisition will see Saga integrated into Roche’s subsidiary, Foundation Medicine, which focuses on advanced genomic profiling and personalised cancer care.

By integrating Aicuris into its global development and commercialization infrastructure, Asahi Kasei accelerates its expansion in the specialty pharmaceutical sector.